Healthcare & Life Sciences
Gossamer Bio
United Statesgossamerbio.com
Gossamer Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 2 tracked investors.
Activeseed
seed
Stage
2
Investors
About Gossamer Bio
Gossamer Bio is a company headquartered in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Gossamer Bio is a clinical-stage biopharmaceutical company developing seralutinib, an inhaled inhibitor targeting PDGFRα/β, CSF1R, and c-KIT, for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Explore Gossamer Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.